This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.62 firm fixed-price contract, awarded on November 5, 2024, is for the delivery of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product, with a performance period through November 6, 2024. This is a delivery order contract, and no set-aside designation was used.
Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/4/25, 10:36 AM